Virax Biolabs VRAX
NASDAQ VRAX
$2.21 -0.02 (-0.90%)
As of: Sep 30, 2026 · 9:58 AM EDT

Virax Biolabs (VRAX) Operating Leases (2023 - 2026)

Updated

Virax Biolabs (VRAX) posted Operating Leases of $304,808 for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 4.5% from $291,543 a year earlier.

Analysis

Virax Biolabs (VRAX) Operating Leases (2023 - 2026) Analysis & Trends

Since fiscal Q2 2024, Virax Biolabs has reported Operating Leases for 6 quarters.

  • In prior fiscal years, Virax Biolabs' Operating Leases was $291,543 in FY2025 (+65.3%) and $176,345 in FY2024.
  • The fiscal Q4 2026 figure stands as the highest quarterly Operating Leases since fiscal Q2 2025.
  • On a year-over-year basis, Operating Leases increased in three of the last four quarters, with growth averaging 51.1%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Virax Biolabs 934,336.46 -20.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 304,808.00
Sep 30, 2025 276,043.00
Mar 31, 2025 291,543.00
Sep 30, 2024 332,098.00
Mar 31, 2024 176,345.00
Sep 30, 2023 132,027.00
API Access

Virax Biolabs Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=VRAX&period=max&api_key=YOUR_API_KEY